Exchange: NASDAQ·Updated 07:30 PM EDT
LIMN logo

LIMN Liminatus Pharma Inc.

$3.71
$0.01
(0.27%)
Today
Closed $3.71
$0.02
(0.54%)
After Hours
Mkt Cap$4.98M
Vol23,256.00

About LIMN

Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
42

Bearish Sentiment

How do you feel about LIMN?

Advertisement|Remove ads.